116 related articles for article (PubMed ID: 18654098)
1. Evaluation of heart failure management in a Military Hospital.
Guiraudet O; Lambert de Crémeur G; Bonnevie L; Héno P; Pelletier C; Fraboulet R; Schiano P; Martin AC; Chenilleau MC; Delarbre D; Chanudet X
Arch Cardiovasc Dis; 2008 Apr; 101(4):235-41. PubMed ID: 18654098
[TBL] [Abstract][Full Text] [Related]
2. Hospital management of heart failure: improvement but still room for improvement at discharge..
Cohen-Solal A
Arch Cardiovasc Dis; 2008 Apr; 101(4):202-3. PubMed ID: 18654093
[No Abstract] [Full Text] [Related]
3. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
[TBL] [Abstract][Full Text] [Related]
5. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of intensified, N-terminal pro brain natriuretic peptide-guided compared with standard medical therapy in elderly patients with congestive heart failure: results from TIME-CHF.
Sanders-van Wijk S; Muzzarelli S; Neuhaus M; Kiencke S; Maeder M; Estlinbaum W; Tobler D; Mayer K; Erne P; Pfisterer ME; Brunner-La Rocca HP;
Eur J Heart Fail; 2013 Aug; 15(8):910-8. PubMed ID: 23666681
[TBL] [Abstract][Full Text] [Related]
7. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
8. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
Houpe D; Peltier M; Cohen-Solal A; Béguin M; Lévy F; Slama M; Chapelain K; Tribouilloy C
Int J Cardiol; 2005 Sep; 103(3):286-92. PubMed ID: 16098391
[TBL] [Abstract][Full Text] [Related]
9. A management programme for suspected heart failure in primary care in cooperation with specialists in cardiology.
Mejhert M; Kahan T
Eur J Gen Pract; 2015 Mar; 21(1):26-32. PubMed ID: 25342003
[TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-B-type natriuretic peptide-guided treatment for chronic heart failure: results from the BATTLESCARRED (NT-proBNP-Assisted Treatment To Lessen Serial Cardiac Readmissions and Death) trial.
Lainchbury JG; Troughton RW; Strangman KM; Frampton CM; Pilbrow A; Yandle TG; Hamid AK; Nicholls MG; Richards AM
J Am Coll Cardiol; 2009 Dec; 55(1):53-60. PubMed ID: 20117364
[TBL] [Abstract][Full Text] [Related]
11. The benefits of using a heart failure management programme in Swedish primary healthcare.
Agvall B; Alehagen U; Dahlström U
Eur J Heart Fail; 2013 Feb; 15(2):228-36. PubMed ID: 23109650
[TBL] [Abstract][Full Text] [Related]
12. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
Michtalik HJ; Yeh HC; Campbell CY; Haq N; Park H; Clarke W; Brotman DJ
Am J Cardiol; 2011 Apr; 107(8):1191-5. PubMed ID: 21296322
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
Bhardwaj A; Rehman SU; Mohammed AA; Gaggin HK; Barajas L; Barajas J; Moore SA; Sullivan D; Januzzi JL
Am Heart J; 2012 Nov; 164(5):793-799.e1. PubMed ID: 23137512
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure.
Zile MR; Claggett BL; Prescott MF; McMurray JJ; Packer M; Rouleau JL; Swedberg K; Desai AS; Gong J; Shi VC; Solomon SD
J Am Coll Cardiol; 2016 Dec; 68(22):2425-2436. PubMed ID: 27908347
[TBL] [Abstract][Full Text] [Related]
15. Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients.
Stienen S; Salah K; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Tijssen JP; Pinto YM; Kok WE
JACC Heart Fail; 2016 Sep; 4(9):736-45. PubMed ID: 27395353
[TBL] [Abstract][Full Text] [Related]
16. Utilisation of medications recommended for chronic heart failure and the relationship with annual hospitalisation duration in patients over 75 years of age. A pharmacoepidemiological study.
Maison P; Cunin P; Hemery F; Fric F; Elie N; Del'volgo A; Dubois-Randé JL; Hittinger L; Macquin-Mavier I
Eur J Clin Pharmacol; 2005 Jul; 61(5-6):445-51. PubMed ID: 15940531
[TBL] [Abstract][Full Text] [Related]
17. Reducing readmissions for congestive heart failure.
Hoyt RE; Bowling LS
Am Fam Physician; 2001 Apr; 63(8):1593-8. PubMed ID: 11327436
[TBL] [Abstract][Full Text] [Related]
18. First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.
Tuppin P; Cuerq A; de Peretti C; Fagot-Campagna A; Danchin N; Juillière Y; Alla F; Allemand H; Bauters C; Drici MD; Hagège A; Jondeau G; Jourdain P; Leizorovicz A; Paccaud F
Arch Cardiovasc Dis; 2013 Nov; 106(11):570-85. PubMed ID: 24140417
[TBL] [Abstract][Full Text] [Related]
19. Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure.
Watz R; Ekstrand AB; Engelbrektson V; Beermann B
Eur J Clin Pharmacol; 2005 May; 61(3):209-14. PubMed ID: 15761755
[TBL] [Abstract][Full Text] [Related]
20. Comparison of one-year outcome (death and rehospitalization) in hospitalized heart failure patients with left ventricular ejection fraction >50% versus those with ejection fraction <50%.
Ezekowitz JA; Lee DS; Tu JV; Newman AM; McAlister FA
Am J Cardiol; 2008 Jul; 102(1):79-83. PubMed ID: 18572040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
